North America Respiratory Care Devices Market

The North America respiratory care devices market is projected to reach USD 15.31 billion by 2031 from USD 10.53 billion in 2026, at a CAGR of 7.8% during the forecast period. A complex interplay of interconnected factors shapes the North America respiratory care devices market. The rising prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other respiratory disorders, worsened by risky lifestyle factors like smoking and long-term environmental exposure, has resulted in an ongoing demand for therapeutic, monitoring, and diagnostic respiratory devices. Meanwhile, North America's strong healthcare system, equipped with advanced medical facilities, high per capita healthcare spending, and well-structured reimbursement policies, enables the rapid adoption of sophisticated technologies such as portable ventilators, smart inhalers, CPAP/BiPAP machines, and connected monitoring systems. Moreover, the region is also experiencing an increase in its elderly population. Because this age group is more vulnerable to respiratory diseases, it will require long-term respiratory support, further expanding the market. Lastly, technological progress and a better understanding of early disease control and home care options are encouraging patients and healthcare providers to adopt advanced respiratory care solutions that align with hospital care but are delivered outside the traditional hospital setting. Hence, the market growth is being maintained.

Some of the prominent players operating in the market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (USA), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), and other players.

To know about the assumptions considered for the study download the pdf brochure

The main factor that has allowed Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (USA), Fisher & Paykel Healthcare Limited (New Zealand), and Drgerwerk AG & Co. KGaA (Germany) to be key players in the North American respiratory care devices market is a combination of their strategic capabilities and market dynamics. These companies offer a diversified and extensive range of products, including ventilators, CPAP/BiPAP devices, oxygen therapy solutions, humidification systems, and advanced monitoring systems, covering the major segments. Thus, their products can be used in both hospital acute care and home care settings. Their R&D expenditure is average in the industry. Thus, they develop innovations that make their equipment more productive, enhance connectivity, and provide more user-friendly interfaces, meeting the needs of a healthcare community that is always changing. Furthermore, their worldwide presence and deep ties with the healthcare community enable them to reach a broader market and build strong customer loyalty. At the same time, their acquisition and partnership strategies help them operate even more competitively. Apart from brand recognition, expertise, and extensive experience in the respiratory field, these companies also possess other characteristics that enable them to maintain a competitive advantage even in a highly competitive environment.

In December 2025, ResMed received FDA clearance for Smart Comfort, an AI-powered feature. It collects actual sleep data and uses machine learning to suggest the best comfort settings for CPAP therapy, tailored to the individual's needs. This feature is part of a new sleep device that automatically calibrates to the user's needs. It helps new sleep apnea patients gradually get used to the treatment by finding the best settings that balance pressure and comfort. It also increases the likelihood that the patient will stick to the treatment in the long run. The launch of AirSense 11 devices and the myAir app in the U.S. is planned for early 2026, and Smart Comfort will be a part of it.

In April 2025, Drgerwerk AG & Co. KGaA secured US FDA 510(k) clearance for its VentStar Resus heated and VentStar Autobreath heated emergency ventilators, demonstrating that these devices are substantially equivalent to other legally marketed devices. With this approval, the company is permitted to sell these Class II powered emergency ventilators in the US. Still, it must comply with general regulatory controls, such as labeling, manufacturing quality, and device registration requirements.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V., widely recognized as Philips, is a multinational health technology company of Dutch origin, with its headquarters in Amsterdam, Netherlands, and a large business presence in North America. Philips has deliberately diversified its business model from a general electronics conglomerate to a healthcare-focused entity, with major segments comprising Diagnosis & Treatment, Connected Care, and Personal Health. Through its Connected Care and Personal Health divisions, Philips designs and sells a broad assortment of respiratory care solutions, including therapeutic and monitoring devices for patients with chronic respiratory diseases, noninvasive ventilators, and patient management systems. Philips Respironics, a domestic U.S. subsidiary specializing in respiratory equipment and sleep-related breathing therapy products, backs the company's respiratory product lines. Philips integrates a digital health platform with its device assortment, enabling connected care in hospital and home environments and providing a versatile respiratory care solution applicable in both acute and long-term settings in North America.

Medtronic (Ireland)

Medtronic is a world-class medical technology company that primarily operates in North America and holds a significant market share in the respiratory care devices segment. The company produces a wide range of critical care and respiratory products, including ventilators, patient monitoring systems, sensors, and respiratory accessories, all commonly used in hospitals and intensive care units. Medtronic's line of respiratory products, supported by well-known brands and its long-standing relationship with healthcare providers, is focused on the effective management of both acute and chronic respiratory conditions. Through a continuous process of innovation, the development of integrated monitoring platforms, and the leveraging of a strong distribution network in the U.S. and Canada, Medtronic has maintained a competitive and reliable presence in the North American respiratory care devices market.

Market Ranking

The North America respiratory care devices market is highly competitive, with only a few large multinational medical technology companies dominating, primarily because of their deep hospital penetration, large product portfolios, and well-established service and distribution networks throughout the U.S. and Canada. To a great extent, the top players in the region include Koninklijke Philips N.V., Medtronic, ResMed Inc., Fisher & Paykel Healthcare Limited, and Drgerwerk AG & Co. KGaA. Their extensive range of ventilators, noninvasive ventilation systems, oxygen therapy devices, and connected respiratory monitoring solutions is a strong point. In addition, these companies have developed a strong network of partners with leading healthcare systems. Their devices are clinically approved for use in intensive care, emergency care, and home care settings, and they continually invest in R&D to improve performance, comfort, and digital connectivity. The ability to provide combined respiratory care solutions with reliable after-sales service, as well as deployments that can be easily scaled from hospitals to home care providers, has enabled them to gain a significant share of the North American market and maintain their status as top players, even though demand for chronic and acute respiratory management is increasing.

Related Reports:

North America Respiratory Care Device Market by Product (PAP Device, Ventilator, Humidifier, Oxygen Concentrator, Spirometer, Peak Flow Meter, Mask), Disease Indication (Asthma, Infectious Disease), End User (Hospital, Homecare Setting)-Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com